Document:

Exhibit 10.1

 Exhibit 10.1 

UNITED STATES OF AMERICA 
 BEFORE THE 
 BOARD OF GOVERNORS OF THE FEDERAL RESERVE SYSTEM 

WASHINGTON, D.C. 
  

			
	Written Agreement by and between	  	 
		  	Docket No. 11-114-WA /RB-HC
	 PRINCETON NATIONAL BANCORP, INC.
	  	
	 Princeton, Illinois
	  	
	 and
	  	
	 FEDERAL RESERVE BANK OF
	  	
	 CHICAGO
	  	
	 Chicago, Illinois
	  	

 WHEREAS, Princeton National Bancorp, Inc., Princeton. Illinois (“Princeton”), a registered bank
holding company, owns and controls Citizens First National Bank, Princeton, Illinois (the “Bank”), and a nonbank subsidiary; 
 WHEREAS, it is the common goal of Princeton and the Federal Reserve Bank of Chicago (the “Reserve Bank”) to maintain the financial soundness of Princeton so that Princeton may serve as a source
of strength to the Bank; 
 WHEREAS, Princeton and the Reserve Bank have mutually agreed to enter into this Written Agreement
(the “Agreement”); and 
 WHEREAS, on October 24 , 2011, the board of directors of Princeton, at a duly
constituted meeting, adopted a resolution authorizing and directing Thomas D. Ogaard to enter into this Agreement on behalf of Princeton, and consenting to compliance with each and every provision of this Agreement by Princeton and its
institution-affiliated parties, as defined in 

 sections 3(u) and 8(b)(3) of the Federal Deposit Insurance Act, as amended (the “FDI Act”)
(12U.S.C. §§ 1813(u) and 1818(b)(3)). 
 NOW, THEREFORE, Princeton and the Reserve Bank agree as follows: 

 Source of Strength 
 1. The board of directors of Princeton shall take appropriate steps to fully utilize Princeton’s financial and managerial resources, pursuant to section 38A of the FDI Act (12 U.S.C. § 1830 o-l)
and section 225.4 (a) of Regulation Y of the Board of Governors of the Federal Reserve System (the “Board of Governors”) (12 C.F.R. § 225.4(a)), to serve as a source of strength to the Bank, including, but not limited to, taking
steps to ensure that the Bank complies with the Consent Order entered into with the Office of the Comptroller of the Currency dated September 20, 2011, and any other supervisory action taken by the Bank’s federal regulator. 

Dividends and Distributions 
 2. (a) Princeton shall not declare or pay any dividends without the prior written approval of the Reserve Bank and the Director of the Division of Banking Supervision and Regulation (the
“Director”) of the Board of Governors. 
 (b) Princeton shall not directly or indirectly take dividends or any other
form of payment representing a reduction in capital from the Bank without the prior written approval of the Reserve Bank. 
 (c)
Princeton and its nonbank subsidiary shall not make any distributions of interest, principal, or other sums on subordinated debentures or trust preferred securities without the prior written approval of the Reserve Bank and the Director. 

  
 2 

 (d) All requests for prior approval shall be received by the Reserve Bank at least 30 days
prior to the proposed dividend declaration date, proposed distribution on subordinated debentures, and required notice of deferral on trust preferred securities. All requests shall contain, at a minimum, current and projected information on
Princeton’s capital, earnings, and cash flow; the Bank’s capital, asset quality, earnings, and allowance for loan and lease losses; and identification of the sources of funds for the proposed payment or distribution. For requests to
declare or pay dividends, Princeton must also demonstrate that the requested declaration or payment of dividends is consistent with the Board of Governors’ Policy Statement on the Payment of Cash Dividends by State Member Banks and Bank Holding
Companies, dated November 14,1985 (Federal Reserve Regulatory Service, 4-877 at page 4-323). 
 Debt and Stock Redemption

 3. (a) Princeton and any nonbank subsidiary shall not, directly or indirectly, incur, increase, or guarantee any debt
without the prior written approval of the Reserve Bank. All requests for prior written approval shall contain, but not be limited to, a statement regarding the purpose of the debt, the terms of the debt, and the planned source(s) for debt repayment,
and an analysis of the cash flow resources available to meet such debt repayment. 
 (b) Princeton shall not, directly or
indirectly, purchase or redeem any shares of its stock without the prior written approval of the Reserve Bank.  
 Capital Plan

 4. Within 60 days of this Agreement, Princeton shall submit to the Reserve Bank an acceptable written plan to maintain
sufficient capital at Princeton on a consolidated basis. The plan shall, at a minimum, address, consider, and include: 

  
 3 

 (a) The consolidated organization’s and the Bank’s current and future capital
requirements, including compliance with the Capital Adequacy Guidelines for Bank Holding Companies: Risk-Based Measure and Tier 1 Leverage Measure, Appendices A and D of Regulation Y of the Board of Governors (12 C.F.R. Part 225, App. A and D) and
the applicable capital adequacy guidelines for the Bank issued by the Bank’s federal regulator; 
 (b) the adequacy of the
Bank’s capital, taking into account the volume of classified credits, concentrations of credit, allowance for loan and lease losses, current, and projected asset growth, and projected retained earnings; 

(c) the source and timing of additional funds necessary to fulfill the consolidated organization’s and the Bank’s future
capital requirements; 
 (d) supervisory requests for additional capital at the Bank or the requirements of any supervisory
action imposed on the Bank by its federal regulator; and 
 (e) the requirements of section 38A of the FDI Act and section
225,4(a) of Regulation Y of the Board of Governors that Princeton serve as a source of strength to the Bank. 
 5. Princeton
shall notify the Reserve Bank, in writing, no more than 45 days after the end of any quarter in which any of Princeton’s capital ratios fall below the approved plan’s minimum ratios. Together with the notification, Princeton shall submit
an acceptable written plan that details the steps that Princeton will take to increase Princeton’s capital ratios to or above the approved plan’s minimums. 
 Cash Flow Projections 
 6. Within 60 days of this Agreement, Princeton shall
submit to the Reserve Bank a written statement of its planned sources and uses of cash for debt service, operating expenses, and other purposes (“Cash Flow Projection”) for 2012. Princeton shall submit to the Reserve 

  
 4 

 Bank a Cash Flow Projection for each calendar year subsequent to 2012 at least one month prior to the
beginning of that calendar year. 
 Compliance with Laws and Regulations 

7. (a) In appointing any new director or senior executive officer, or changing the responsibilities of any senior executive officer so
that the officer would assume a different senior executive officer position, Princeton shall comply with the notice provisions of section 32 of the FDJ Act (12 U.S.C. §18311) and Subpart H of Regulation Y of the Board of Governors (12 C.F.R.
§§225.71 etseg.’). 
 (b) Princeton shall comply with the restrictions on indemnification and severance
payments of section 18(k) of the FDI Act (12 U.S.C. § 1828(k)) and Part 359 of the Federal Deposit Insurance Corporation’s regulations (12 C.F.R. Part 359). 
 Progress Reports 
 8. Within 45 days after the end of each calendar quarter
following the date of this Agreement, the board of directors shall submit to the Reserve Bank written progress reports detailing the form and manner of all actions taken to secure compliance with the provisions of this Agreement and the results
thereof, and a parent company only balance sheet, income statement, and, as applicable, report of changes in stockholders’ equity. 

Approval and Implementation of Flan 
 9. (a) Princeton shall submit a written capital plan that is acceptable to the Reserve Bank within the applicable time period set forth in paragraph 4 of this Agreement. 

(b) Within 10 days of approval by the Reserve Bank, Princeton shall adopt the approved capital plan. Upon adoption, Princeton shall
promptly implement the approved plan, and thereafter fully comply with it. 

  
 5 

 (c) During the term of this Agreement, the approved capital plan shall not be amended or
rescinded without the prior written approval of the Reserve Bank. 
 Communications 

10. All communications regarding this Agreement shall be sent to: 

(a) Mr. David A. Ward 
 Assistant Vice President 
 Federal Reserve Bank of Chicago 

230 South LaSalle Street 
 Chicago, Illinois 60604-1413 
 (b) Mr. Thomas D. Ogaard

 President and Chief Executive Officer 
 Princeton National Bancorp, Inc. 
 606 South Main Street 

Princeton, Illinois 61356 

Miscellaneous 
 11.
Notwithstanding any provision of this Agreement, the Reserve Bank may, in its sole discretion, grant written extensions of time to Princeton to comply with any provision of this Agreement. 

12. The provisions of this Agreement shall be binding upon Princeton and its institution-affiliated parties, in their capacities as such,
and their successors and assigns. 
 13. Each provision of this Agreement shall remain effective and enforceable until stayed,
modified, terminated, or suspended in writing by the Reserve Bank. 
 14. The provisions of this Agreement shall not bar, estop,
or otherwise prevent the Board of Governors, the Reserve Bank, or any other federal or state agency from taking any other action affecting Princeton, the Bank, any nonbank subsidiary of Princeton, or any of their current or former
institution-affiliated parties and their successors and assigns. 

  
 6 

 15. Pursuant to section 50 of the FDI Act(12U.S.C. § 183laa), this Agreement is
enforceable by the Board of Governors under section 8 of the FD1 Act (12 U.S.C. § 1818). 
 IN WITNESS WHEREOF, the parties
have caused this Agreement to be executed as of the 27th day of October, 2011. 
  

									
	 PRINCETON NATIONAL

BANCORP, INC.
	 		 	 FEDERAL RESERVE BANK

OF CHICAGO

					
	By:	 	Thomas D. Ogaard	 		 	By:	 	/s/ Mark H. Kawa
		 	President & CEO	 		 		 	  Mark H. Kawa
		 		 		 		 	  Vice President

  
 7Severance Agreement

 Exhibit 10.162 

 

							
	 Employee
	  	Section 2.01 Base Salary
and Bonus Multiplier	 	  	Section 2.03 Welfare
Benefit Period
			
	 Fredric N. Eshelman
	  	 	3.0	  	  	2 years
	 Raymond H. Hill*
	  	 	2.99	  	  	2 years
	 William Sharbaugh
	  	 	2.0	  	  	2 years
	 Daniel G. Darazsdi
	  	 	2.0	  	  	2 years
	 Christine A. Dingivan
	  	 	2.0	  	  	2 years
	 Brainard Judd Hartman
	  	 	2.0	  	  	2 years
	 Michael O. Wilkinson
	  	 	1.0	  	  	1 year  
	 Edward J. Murray
	  	 	1.0	  	  	1 year  
	 Paul D. Colvin
	  	 	1.0	  	  	1 year  
	 Lee E. Babiss
	  	 	1.0	  	  	1 year  
	 Henrietta N. Ukwu
	  	 	1.0	  	  	1 year  
	 William W. Richardson
	  	 	1.0	  	  	1 year  
	 Sebastian Pacios Merino
	  	 	1.0	  	  	1 year  
	 Bruce A. Petersen
	  	 	1.0	  	  	1 year  
	 Susan Atkinson
	  	 	1.0	  	  	1 year  

  

	*	See Exhibit 10.282 for a copy of Raymond H. Hill’s severance agreement. 

 SEVERANCE AGREEMENT 

THIS AGREEMENT, effective the 1st day of January, 2001, by and between Pharmaceutical Product Development, Inc. and its subsidiaries and
affiliates (collectively, “PPD”) and                                 
(“Employee”). 
 WHEREAS, Employee is a valued employee of PPD and in order to induce Employee to remain in the employ
of PPD, PPD desires to provide the severance benefits hereinafter described in the event of a “Change in Control”, as hereinafter defined, of PPD. 
 NOW, THEREFORE, it is agreed as follows: 
 1. Definitions

 1.01 “AFR” means the interest rate determined under Section 1274 of the Code. 

1.02 “Base Amount” shall have the meaning set forth and shall be determined as provided in Section 280G of the
Code. 
 1.03 “Change in Control” means (i) a change of control of a nature that would be required to be
reported in response to Item 6(e) of Schedule 14A of Regulation 14A promulgated under the Securities Exchange Act of 1934, as amended (“Exchange Act”), provided that such a Change in Control shall be deemed to have occurred if any
“person” (as such term is used in Sections 13(d) and 14(d)(2) of the Exchange Act) is or becomes the beneficial owner, directly or indirectly, of securities of PPD representing 50% or more of the combined voting power of PPD’s then
outstanding securities; (ii) a sale of substantially all of the assets of PPD; or (iii) a liquidation of PPD. 

1.04 “Constructive Termination” means a termination of Employee’s employment by PPD during the Covered Period
initiated by Employee after (i) a substantial diminution or alteration in the duties of Employee, (ii) a reduction by PPD in Employee’s base salary in effect on the date of the Change in Control, or (iii) the relocation of
Employee’s primary work location to a location that is more than twenty-five (25) miles from Employee’s primary work location prior to the Change in Control. Constructive Termination specifically does not include termination of
Employee by reason of death, Disability or retirement at or after age 65. Employee shall give PPD written notice of a Constructive Termination, which notice shall provide a brief 

 
description of the circumstances which Employee asserts gives rise to a right of Constructive Termination, and PPD shall have ten (10) days from receipt of said notice within which to remedy
said circumstances. 
 1.05 “Covered Payment” means the amounts and benefits paid to Employee pursuant to this
Agreement, taken together with any amounts or benefits otherwise paid or distributed to Employee by PPD. 
 1.06
“Covered Period” means the time period commencing on the date of and coincident with a Change of Control and ending one year thereafter. 
 1.07 “Disability” means the inability of Employee to perform his assigned duties for PPD for a period of three (3) months due to Employee’s physical or mental illness as
determined by a reputable medical doctor. 
 1.08 “Excess Parachute Payment” shall have the meaning set forth
and shall be determined as provided in Section 280G of the Code. 
 1.09 “Excise Tax” shall mean the tax
imposed under Section 4999 of the Code on an Excess Parachute Payment. 
 1.10 “Executive Consultant”
shall mean the executive compensation or comparable consultant used from time to time by PPD in designing its compensation program for executive and senior management employees of PPD; provided, however, that in its sole discretion PPD may at any
time designate its independent auditors as its Executive Consultant for the purpose of performing any calculations required under Section 2.05 of this Agreement. 
 1.11 “Final Determination” means a final determination by a court of competent jurisdiction or a proceeding of the Internal Revenue Service or its successor agency. 

1.12 “First Period” means the twelve-month period ending on the Termination Date. 

1.13 “Internal Revenue Code” means the Internal Revenue Code of 1986 as heretofore or hereafter amended, and any
successor code. References in this agreement to specific sections of the Code shall also include any successor sections. 

1.14 “Parachute Payments” shall have the meaning set forth and shall be determined as provided in Section 280G of
the Code. 
 1.15 “Payment Cap” means the maximum amount which may be paid to Employee under the terms of this
Agreement without subjecting Employee to the Excise Tax. 

 1.16 “Payment Date” means the date thirty (30) days following the
Termination Date. 
 1.17 “Stock Awards” means Employee’s outstanding awards of PPD non-qualified stock
options or restricted stock as of the Termination Date. 
 1.18 “Termination for Cause” means (i) an act
or acts involving fraud, embezzlement or theft from PPD, (ii) Employee’s willful and repeated failure to follow directions of the Board of Directors that continues for at least ten (10) days following written notice of the Board of
Directors of such failure to follow directions, or (iii) termination for cause as defined in and made pursuant to a then effective employment agreement, if any, between Employee and PPD. 

1.19 “Termination Date” means the date on which Employee’s employment is terminated such that Employee is entitled
to the compensation and benefits provided for in Section 2 of this Agreement. 
 2. Compensation Upon Change of
Control. If during the Covered Period (i) PPD terminates Employee’s employment for reason other than Termination for Cause or (ii) Employee’s employment is terminated by reason of Constructive Termination, Employee shall
be entitled to the following compensation and benefits: 
 2.01 Base Salary and Bonus. PPD shall pay Employee an amount
equal to                      times the sum of Employee’s (i) base salary for the First Period (determined as if Employee was employed for
the entire First Period if employed for less than the First Period) and (ii) the greater of (x) Employee’s target bonus under the PPD incentive cash bonus plan in which Employee is eligible to participate immediately prior to the
Termination Date or (y) the average of the cash bonuses received in the First Period and in the twelve-month period immediately preceding the First Period, said amount to be paid on the Payment Date. 

2.02 Unpaid and Deferred Compensation. PPD shall pay Employee any bonus or deferred compensation (whether in the form of cash,
stock or otherwise) accrued but unpaid as of the Termination Date, said sum to be paid on the Payment Date. 
 2.03 Benefits.
For a period of                      after the Termination Date, PPD shall continue to pay for and provide welfare benefits which Employee was
receiving immediately prior to the Termination Date, including life insurance, health, medical, dental, vision and wellness, accidental death and dismemberment and disability benefits; provided, however, that PPD’s obligations under this clause
shall terminate from the date that Employee first becomes eligible after the Termination Date for similar coverage under another employer’s plan. 
 2.04 Stock Awards. Notwithstanding anything to the contrary in any agreement for Stock Awards, (i) all unvested shares underlying Stock Awards granted more than six months prior to the
Termination Date shall become fully vested as of the 

 
Termination Date, and (ii) Employee shall continue to be treated under each award agreement evidencing a Stock Award as if Employee was an employee of PPD until the first to occur of
(x) the third anniversary of the Termination Date, or (y) the expiration of the exercise period provided for therein; provided, however, in the event of Employee’s death or his disability (as disability is defined in the award
agreement) after the Termination Date, the time for exercise after death or such disability prescribed in the award agreement shall apply. The provisions of this Section 2.04 shall also apply to any and all substitute awards for nonqualified
stock options and restricted stock granted to Employee in exchange for Stock Awards to which this section applies. 
 2.05
Limitation on Payments. 
 a. Application of Section 2.05. If a Covered Payment hereunder would be an Excess
Parachute Payment and would thereby subject Employee to the Excise Tax, the provisions of this Section 2.05 shall apply to determine the amounts payable to Employee pursuant to this Agreement. 

b. Calculation of Benefits. At least fifteen (15) days prior to the Payment Date, PPD shall notify Employee of the aggregate
present value of all amounts and benefits to which Employee would be entitled under this Agreement and any other plan, program or arrangement with PPD as of the Termination Date, together with the projected maximum payments, determined as of such
Date of Termination, that could be paid without Employee being subject to the Excise Tax. 
 c. Imposition of Payment Cap.
If (i) the aggregate value of all amounts and benefits to which Employee would be entitled under this Agreement and any other plan, program or arrangement with PPD exceeds the amount which can be paid to Employee without Employee incurring
an Excise Tax and (ii) Employee would receive a greater net after-tax amount (taking into account all applicable taxes payable by Employee, including an Excise Tax) by applying the limitation contained in this Section 2.05(c), then the
amounts otherwise payable to Employee under this Section 2 shall be reduced to an amount equal to the Payment Cap. If Employee receives reduced payments and benefits hereunder, Employee shall have the right to designate which of the payments
and benefits otherwise provided for in this Agreement that Employee will receive in connection with the application of the Payment Cap. 
 d. Application of Code Section 280G. The Executive Consultant shall determine whether any part of the Covered Payment will be subject to the Excise Tax and the amount of such Excise Tax. For
purposes of such determination, the Executive Consultant shall take into consideration and be guided by the following: 

(i) such Covered Payment will be treated as Parachute Payments and all Parachute Payments in excess of the Base Amount shall be
treated as subject to the Excise Tax, unless and except to the extent that in the good faith judgment of the Executive Consultant, PPD has a reasonable basis to conclude that such Covered Payment, in whole or in part, either do not constitute
Parachute Payments or represent 

 
reasonable compensation for personal services actually rendered (within the meaning of Section 280G of the Code) in excess of the Base Amount, or such Parachute Payments are otherwise not
subject to the Excise Tax, and 
 (ii) the value of any noncash benefits or any deferred payment or benefit shall be
determined by the Executive Consultant in accordance with the principles of Section 280G of the Code. 
 (e) Applicable
Tax Rates. For purposes of determining whether Employee would receive a greater net after-tax benefit if the amounts payable under this Agreement are reduced in accordance with Section 2.05(c), Employee shall be deemed to pay: 

(i) federal income taxes at the highest applicable marginal rate of federal income taxation for the calendar year in which the
first amounts are to be paid hereunder, and 
 (ii) any applicable state and local income taxes at the highest
applicable marginal rate of taxation for such calendar year, net of the maximum reduction in federal income taxes which could be obtained from the deduction of such state or local taxes if paid in such year; 

provided, however, that Employee may request that such determination be made based on Employee’s individual tax circumstances, which shall govern
such determination so long as Employee provides to the Executive Consultant such information and documents as the Executive Consultant shall reasonably request to determine such individual circumstances. 

(f) Adjustments in Respect to Payment Cap. 
 (i) If Employee receives reduced payments and benefits under Section 2.05 or if Section 2.05 is determined not to be applicable to Employee because the Executive Consultant concludes that
Employee is not subject to any Excise Tax, and it is established pursuant to a Final Determination that, notwithstanding the good faith of Employee and PPD in applying the terms of this Agreement, the aggregate Parachute Payments paid to Employee or
for Employee’s benefit are in an amount that would result in Employee being subject to an Excise Tax and Employee would still be subject to the Payment Cap under the provisions of Section 2.05(c), then the amount in excess of the Payment
Cap shall be deemed for all purposes to be a loan to Employee made on the date of the receipt of such excess payment, which Employee shall have an obligation to repay to PPD on demand, together with interest at the AFR, from the date of the payment
hereunder to the date of repayment by Employee. 
 (ii) If Section 2.05 is not applied to reduce Employee’s
entitlements under this Section 2 because the Executive Consultant determines that Employee would not receive a greater net after-tax benefit by applying Section 2.05 and 

 
it is established pursuant to a Final Determination that, notwithstanding the good faith of Employee and PPD in applying the terms of this Agreement, Employee would have received a greater net
after-tax benefit by subjecting Employee’s payments and benefits hereunder to the Payment Cap, then the aggregate Parachute Payments paid to Employee or for Employee’s benefit in excess of the Payment Cap shall be deemed for all purposes a
loan to Employee made on the date of receipt of such excess payments, which Employee shall have an obligation to repay to PPD on demand, together with interest at the AFR, from the date of payment hereunder to the date of repayment by Employee.

 (iii) If Employee receives reduced payments and benefits by reason of this Section 2.05 and it is established
pursuant to a Final Determination that Employee could have received a greater amount without exceeding the Payment Cap, then PPD shall promptly thereafter pay Employee the aggregate additional amount which could have been paid without exceeding the
Payment Cap, together with interest on such amount at the AFR, from the original payment due date to the date of actual payment by PPD. 
 3. Miscellaneous. 
 3.01 Successor-in-Interest. PPD will
require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of PPD, to expressly assume and agree to perform this Agreement in the same manner and to
the same extent that PPD would be required to perform it if no succession had taken place. 
 3.02 Binding Effect. This
Agreement shall inure to the benefit of and be enforceable by Employee’s personal or legal representatives, executives, administrators, successors, heirs, distributees, devisees and legatees. 

3.03 Notice. For purposes of this Agreement, notices and all other communications provided for in the Agreement shall be in
writing and shall be given (i) by certified mail, return receipt requested, postage prepaid, (ii) by personal delivery or (iii) by recognized overnight carrier, and shall be deemed received when actually received. Notices shall be
addressed as follows: 
  

					
	If to PPD:	  	Pharmaceutical Product Development, Inc.
		  	929 North Front Street
		  	Wilmington, North Carolina 28401
		  	Attention: Chief Executive Officer
			
	If to Employee:	  	  
	  	
		  	  
	  	
		  	  
	  	
		  	  
	  	

 Either party hereto may change the notice address by giving notice thereof in the manner provided for
herein. 
 3.04 Waiver. No waiver by either party hereto at any time of any breach by the other party hereto of, or
compliance with, any provision or condition of this Agreement to be performed by such other party shall be deemed a subsequent waiver of the same or similar provisions or conditions. 

3.05 Entire Agreement. No agreements or representations, oral or otherwise, expressed or implied, with respect to the subject
matter hereof have been made by either party which are not set forth expressly in this agreement, and this Agreement supersedes and replaces in its entirety all prior agreements and representations, expressed, implied, oral or otherwise, made by PPD
to or with Employee, including but not limited to that certain Severance Agreement dated                      between PPD and Employee. 

3.06 Governing Law. This Agreement shall be governed by and interpreted under the laws of the State of North Carolina. 

3.07 Unenforceability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or
enforceability of any other provision of this Agreement. 
 3.08 Counterparts. This Agreement may be executed in one or
more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. 
 3.09 Headings. Headings used in this Agreement are for convenience only and shall not be used to construe or interpret this Agreement. 

3.10 Enforcement by Employee. All legal expenses incurred by Employee in the successful enforcement of any of the terms of this
Agreement shall be paid by PPD. 
 IN WITNESS WHEREOF, the parties have executed this Agreement effective the date first
hereinabove set forth. 
  

							
	Pharmaceutical Product Development, Inc.	 		 	Employee
				
	By:	 	  
	 		 	  

	Name:	 		 		 	Name:
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]